The science of safety: complications associated with the use of mechanical circulatory support in cardiogenic shock and best practices to maximize safety

F1000Res. 2020 Jul 29:9:F1000 Faculty Rev-794. doi: 10.12688/f1000research.25518.1. eCollection 2020.

Abstract

Acute mechanical circulatory support (MCS) devices are widely used in cardiogenic shock (CS) despite a lack of high-quality clinical evidence to guide their use. Multiple devices exist across a spectrum from modest to complete support, and each is associated with unique risks. In this review, we summarize existing data on complications associated with the three most widely used acute MCS platforms: the intra-aortic balloon pump (IABP), Impella systems, and veno-arterial extracorporeal membrane oxygenation (VA-ECMO). We review evidence from available randomized trials and highlight challenges comparing complication rates from case series and comparative observational studies where a lack of granular data precludes appropriate matching of patients by CS severity. We further offer a series of best practices to help shock practitioners minimize the risk of MCS-associated complications and ensure the best possible outcomes for patients.

Keywords: Safety review; acute mechanical circulatory support; cardiogenic shock; ecmo; impella; intraaortic balloon pump.

Publication types

  • Review

MeSH terms

  • Heart-Assist Devices / adverse effects
  • Humans
  • Intra-Aortic Balloon Pumping / adverse effects
  • Shock, Cardiogenic* / therapy
  • Time Factors
  • Treatment Outcome

Grants and funding

The author(s) declared that no grants were involved in supporting this work.